A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY OF PF-06821497 (MEVROMETOSTAT) IN COMBINATION WITH ENZALUTAMIDE COMPARED WITH ENZALUTAMIDE OR DOCETAXEL IN PARTICIPANTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER PREVIOUSLY TREATED WITH ABIRATERONE ACETATE (MEVPRO-1)

  • Herbison, Harriet (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date25/10/24 → 24/10/29

Clinical Trial Phase

  • Phase III (a & b)